c2H2/c3C1, a two-MAb cocktail with high therapeutic efficacy against SARS-CoV-2 infections Jan. 21, 2021
Gemcitabine can be repurposed as anti-HEV agent, in particular for HEV-infected cancer patients Jan. 20, 2021
ConserV and Lawrence Livermore National Laboratory collaborate on broad-spectrum coronavirus vaccine Jan. 20, 2021
RSS